Home/Filings/4/0001181431-09-006862
4//SEC Filing

O'Toole David D. 4

Accession 0001181431-09-006862

CIK 0001409012other

Filed

Feb 4, 7:00 PM ET

Accepted

Feb 5, 6:29 PM ET

Size

6.0 KB

Accession

0001181431-09-006862

Insider Transaction Report

Form 4
Period: 2009-02-03
O'Toole David D.
CFO & Executive VP
Transactions
  • Award

    Restricted Stock Units

    2009-02-03+1,2411,241 total
    Common Stock (1,241 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents a contingent right to receive one share of Abraxis BioScience common stock.
  • [F2]25% of the restricted stock units vest on the date of grant and the remaining units vests in 2 equal installments on January 15, 2010 and January 15, 2011. Vested shares will be delivered to the reporting person on each vesting date.

Issuer

Abraxis BioScience, Inc.

CIK 0001409012

Entity typeother

Related Parties

1
  • filerCIK 0001437047

Filing Metadata

Form type
4
Filed
Feb 4, 7:00 PM ET
Accepted
Feb 5, 6:29 PM ET
Size
6.0 KB